informaworld logo
HOME . ABOUT US . CONTACT US 		HELP . PUBLISH WITH US . LIBRARIANS 
ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 
Advert: Informa Healthcare - http://www.informahealthcare.com

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Forthcoming Articles       Aims & Scope       Editorial Board       Instructions for Authors       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal

Leukemia and Lymphoma, Volume 50 Issue 11 2009

Leukemia and Lymphoma is moving!
2008 Impact Factor: 1.939 (© Thomson Reuters, Journal Citation Reports®, 2009)
ISSN: 1029-2403 (electronic) 1042-8194 (paper)
Publication Frequency: 12 issues per year
Viewing the Journal: Select the initial letter of your research topic from the list below, or enter your search term on the left.
Sort by: Title | Page | Author
< Previous • 1 • 2 • Next >
View new articles ahead of the print edition
select-down Click for help
Commentary
Is there a role for bone scan in Hodgkin lymphoma in the age of 18F-fluorodeoxyglucose positron emission tomography?
Peter Martin
Pages 1731 – 1732
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?
Dennis A. Eichenauer; Andreas Engert
Pages 1733 – 1734
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Screening for microRNAs in myelodysplastic syndromes
Elizabeth A. Eklund; Leonidas C. Platanias
Pages 1735 – 1736
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
The role of myeloid colony-stimulating factors in the treatment of acute lymphoblastic leukemia – more questions than answers?
Ron Ram; Pia Raanani
Pages 1737 – 1739
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise?
Arjan Diepstra
Pages 1740 – 1741
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Another great medical mimic: intravascular lymphoma
John Anastasi
Pages 1742 – 1743
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Workshop Reviews (Deauville, April 2009)
Early detection of patients with poor risk diffuse large B-cell lymphoma
Laurie H. Sehn
Pages 1744 – 1747
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments
Josée M. Zijlstra;  Ronald Boellaard; Otto S. Hoekstra
Pages 1748 – 1749
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes
Teruhiko Terasawa; Hirokazu Nagai
Pages 1750 – 1752
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation – where do we stand?
Michel Meignan;  Emmanuel Itti;  Andrea Gallamini; Corinne Haioun
Pages 1753 – 1756
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas – the PETAL trial
Ulrich Dührsen;  Andreas Hüttmann;  Karl-Heinz Jöckel; Stefan Müller
Pages 1757 – 1760
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation
Andrea Gallamini;  Francesca Fiore;  Roberto Sorasio; Michel Meignan
Pages 1761 – 1764
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Reviews
Good things come in small packages: low-dose radiation as palliation for indolent non-Hodgkin lymphomas
Neil E. Martin; Andrea K. Ng
Pages 1765 – 1772
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment
Holbrook Kohrt; Ranjana Advani
Pages 1773 – 1784
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Overcoming resistance in chronic myelogenous leukemia
Susannah Cooper;  Francis J. Giles; Michael R. Savona
Pages 1785 – 1793
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Articles: Clinical
Bone and [18F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults
Barry L. Shulkin;  Geoffrey S. Goodin;  Mary B. McCarville;  Sue C. Kaste;  Matthew J. Krasin;  Melissa M. Hudson; Monika Metzger
Pages 1794 – 1802
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma
Elena Cavalieri;  Angela Matturro;  Giorgia Annechini;  Federico De Angelis;  Natalia Frattarelli;  Fabiana Gentilini;  Lavinia Grapulin;  Mikael Sacco;  Fabio Torelli;  Marco Vignetti;  Franco Mandelli;  Robin Foà; Alessandro Pulsoni
Pages 1803 – 1808
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence
Koen van Besien;  Alexander Dew;  Shang Lin;  Loren Joseph;  Lucy A. Godley;  Richard A. Larson;  Toyosi Odenike;  Elizabeth Rich;  Wendy Stock;  Amittha Wickrema; Andrew S. Artz
Pages 1809 – 1817
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma
Hiroo Katsuya;  Junji Suzumiya;  Hidenori Sasaki;  Kenji Ishitsuka;  Takao Shibata;  Yasushi Takamatsu; Kazuo Tamura
Pages 1818 – 1823
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文（简体和繁體）
© 2009 Informa plc